Summit Therapeutics
SMMT
#1450
Rank
C$20.53 B
Marketcap
C$26.49
Share price
0.58%
Change (1 day)
-3.92%
Change (1 year)

Market capitalization of Summit Therapeutics (SMMT)

Market cap: C$20.53 Billion

As of April 2026 Summit Therapeutics has a market cap of C$20.53 Billion. This makes Summit Therapeutics the world's 1450th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Summit Therapeutics from 2015 to 2026

End of year Market Cap

Year Marketcap Change
2026C$20.53 B11.06%
2025C$18.49 B-4.03%
2024C$19.27 B694.27%
2023C$2.42 B108.97%
2022C$1.16 B246.59%
2021C$0.33 B-32.05%
2020C$0.49 B251.16%
2019C$0.14 B444.66%
2018C$25.77 M-87.6%
2017C$0.20 B46.99%
2016C$0.14 B-27.66%
2015C$0.19 B

End of Day market cap according to different sources

On Mar 31st, 2026 the market cap of Summit Therapeutics was reported to be:

C$20.42 Billion
by Nasdaq info icon info icon
C$20.42 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sarepta Therapeutics
SRPT
C$3.24 B-84.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
C$0.31 B-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
C$0.37 B-98.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
C$8.56 B-58.30%๐Ÿ‡บ๐Ÿ‡ธ USA